Quality control and safety of Prasaprohyai 95%ethanolic extract capsules in healthy volunteer (Clinical Trial phase I)

Phase 1

Completed

• Conditions: Healthy volunteer; Prasaprohyai remedy, safety, complementary medicine, herbal extract

• Registration Number: TCTR20191008002
• Lead Sponsor: Faculty of Medicine, Thammasat univercity

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-04-26
• Study Start: 2019-10-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

The criteria for recruitment were; age 20â€60 years old, healthy, or without serious medical conditions, and able to follow the instructions for 8 weeks.

Exclusion Criteria

The criteria for exclusion were allergic reactions to Prasaprohyai medications, receive other medication, pregnant, lactating women or participate in other studies were excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
laboratory test Week0, 3, 6, 8 Liver function test, renal function test, CBC, FBS, Cholesterol

Secondary Outcome Measures

Name	Time	Method
Side effect Week0, 3,6,8 Record